These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 17206861)

  • 21. 2C4, a monoclonal antibody against HER2, disrupts the HER kinase signaling pathway and inhibits ovarian carcinoma cell growth.
    Takai N; Jain A; Kawamata N; Popoviciu LM; Said JW; Whittaker S; Miyakawa I; Agus DB; Koeffler HP
    Cancer; 2005 Dec; 104(12):2701-8. PubMed ID: 16265675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein expression profiling of primary mammary epithelial cells derived from MMTV-neu mice revealed that HER2/NEU-driven changes in protein expression are functionally clustered.
    Park S; Lee KM; Ju JH; Kim J; Noh DY; Lee T; Shin I
    IUBMB Life; 2010 Jan; 62(1):41-50. PubMed ID: 19960538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mathematical model for the effects of HER2 overexpression on cell proliferation in breast cancer.
    Eladdadi A; Isaacson D
    Bull Math Biol; 2008 Aug; 70(6):1707-29. PubMed ID: 18648887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination.
    Balz LM; Bartkowiak K; Andreas A; Pantel K; Niggemann B; Zänker KS; Brandt BH; Dittmar T
    J Pathol; 2012 Jun; 227(2):234-44. PubMed ID: 22262199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signaling network state predicts twist-mediated effects on breast cell migration across diverse growth factor contexts.
    Kim HD; Meyer AS; Wagner JP; Alford SK; Wells A; Gertler FB; Lauffenburger DA
    Mol Cell Proteomics; 2011 Nov; 10(11):M111.008433. PubMed ID: 21832255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human EGF receptor (HER) family and heregulin members are differentially expressed in epidermal keratinocytes and modulate differentiation.
    De Potter IY; Poumay Y; Squillace KA; Pittelkow MR
    Exp Cell Res; 2001 Dec; 271(2):315-28. PubMed ID: 11716544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EGF-receptor-mediated mammary epithelial cell migration is driven by sustained ERK signaling from autocrine stimulation.
    Joslin EJ; Opresko LK; Wells A; Wiley HS; Lauffenburger DA
    J Cell Sci; 2007 Oct; 120(Pt 20):3688-99. PubMed ID: 17895366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-linear dimensionality reduction of signaling networks.
    Ivakhno S; Armstrong JD
    BMC Syst Biol; 2007 Jun; 1():27. PubMed ID: 17559646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells.
    Ram TG; Kokeny KE; Dilts CA; Ethier SP
    J Cell Physiol; 1995 Jun; 163(3):589-96. PubMed ID: 7775601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells.
    Moffa AB; Tannheimer SL; Ethier SP
    Mol Cancer Res; 2004 Nov; 2(11):643-52. PubMed ID: 15561780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
    Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
    FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.
    Pradeep CR; Zeisel A; Köstler WJ; Lauriola M; Jacob-Hirsch J; Haibe-Kains B; Amariglio N; Ben-Chetrit N; Emde A; Solomonov I; Neufeld G; Piccart M; Sagi I; Sotiriou C; Rechavi G; Domany E; Desmedt C; Yarden Y
    Oncogene; 2012 Aug; 31(31):3569-83. PubMed ID: 22139081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Robust co-regulation of tyrosine phosphorylation sites on proteins reveals novel protein interactions.
    Naegle KM; White FM; Lauffenburger DA; Yaffe MB
    Mol Biosyst; 2012 Oct; 8(10):2771-82. PubMed ID: 22851037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyrosine phosphorylation mapping of the epidermal growth factor receptor signaling pathway.
    Steen H; Kuster B; Fernandez M; Pandey A; Mann M
    J Biol Chem; 2002 Jan; 277(2):1031-9. PubMed ID: 11687594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Network analysis of epidermal growth factor signaling using integrated genomic, proteomic and phosphorylation data.
    Waters KM; Liu T; Quesenberry RD; Willse AR; Bandyopadhyay S; Kathmann LE; Weber TJ; Smith RD; Wiley HS; Thrall BD
    PLoS One; 2012; 7(3):e34515. PubMed ID: 22479638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The catalytic region and PEST domain of PTPN18 distinctly regulate the HER2 phosphorylation and ubiquitination barcodes.
    Wang HM; Xu YF; Ning SL; Yang DX; Li Y; Du YJ; Yang F; Zhang Y; Liang N; Yao W; Zhang LL; Gu LC; Gao CJ; Pang Q; Chen YX; Xiao KH; Ma R; Yu X; Sun JP
    Cell Res; 2014 Sep; 24(9):1067-90. PubMed ID: 25081058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis: distribution of homo- and heterodimers depends on relative HER2 levels.
    Hendriks BS; Opresko LK; Wiley HS; Lauffenburger D
    J Biol Chem; 2003 Jun; 278(26):23343-51. PubMed ID: 12686539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.